SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19
NCT04979871 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2023-05-09
Summary
Analysis of SARS-CoV-2 antibodies and serum virus neutralisation in vaccinated heath care personnel. Analysis of virus neutralisation as a function of age, gender, and history of COVID-19 infection.
Conditions
- Vaccine Reaction
Interventions
- PROCEDURE
-
Venous bleeding
Blood samples collected 5 times with approx. 2-4 weeks interval
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Principal Investigators
-
Pål Johansen, Prof · University of Zurich, Dept. Dermatology
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-07-22
- Primary Completion
- 2021-09-30
- Completion
- 2021-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and Vaccination
NCT04842305 ·Status: UNKNOWN
-
Detection of COVID-19 in Saliva Collection
NCT04386551 ·Status: COMPLETED
-
Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection
NCT04624997 ·Status: UNKNOWN
-
Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.
NCT04596098 ·Status: COMPLETED
-
RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19
NCT04397666 ·Status: UNKNOWN ·Phase: NA
-
Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution
NCT04664023 ·Status: COMPLETED
-
Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study
NCT04888793 ·Status: COMPLETED
-
Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff
NCT04896788 ·Status: UNKNOWN ·Phase: NA
-
Assessment of the Natural Anticoagulant Profile in Patients With COVID-19
NCT05083104 ·Status: UNKNOWN
-
COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children
NCT04448717 ·Status: COMPLETED
-
Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department
NCT04583189 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra
NCT05172167 ·Status: UNKNOWN
-
Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19
NCT05092607 ·Status: UNKNOWN ·Phase: NA
-
SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)
NCT04581148 ·Status: UNKNOWN
-
Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients
NCT04852796 ·Status: COMPLETED
-
Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome.
NCT05145348 ·Status: UNKNOWN
-
Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000584 ·Status: COMPLETED ·Phase: PHASE3
-
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
NCT04707820 ·Status: COMPLETED ·Phase: NA
-
Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.
NCT04322279 ·Status: TERMINATED
-
COVID Infection in Pediatric Surgical Patient
NCT05898529 ·Status: RECRUITING
-
Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)
NCT04355351 ·Status: COMPLETED ·Phase: NA
-
Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain
NCT05087277 ·Status: UNKNOWN
-
The Role of Obesity in Severe COVID-19 Pathophysiology
NCT06968442 ·Status: RECRUITING ·Phase: NA
-
Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers
NCT04525417 ·Status: COMPLETED ·Phase: NA
-
Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 Infection
NCT05000307 ·Status: COMPLETED ·Phase: NA